BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30693564)

  • 1. Public Meets Private: Conversations Between Coca-Cola and the CDC.
    Maani Hessari N; Ruskin G; McKEE M; Stuckler D
    Milbank Q; 2019 Mar; 97(1):74-90. PubMed ID: 30693564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating Coca-Cola's attempts to influence public health 'in their own words': analysis of Coca-Cola emails with public health academics leading the Global Energy Balance Network.
    Serodio P; Ruskin G; McKee M; Stuckler D
    Public Health Nutr; 2020 Oct; 23(14):2647-2653. PubMed ID: 32744984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Big food and drink sponsorship of conferences and speakers: a case study of one multinational company's influence over knowledge dissemination and professional engagement.
    Atli Gunnarsson J; Ruskin G; Stuckler D; Steele S
    Public Health Nutr; 2023 May; 26(5):1094-1111. PubMed ID: 36450363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Always read the small print": a case study of commercial research funding, disclosure and agreements with Coca-Cola.
    Steele S; Ruskin G; McKee M; Stuckler D
    J Public Health Policy; 2019 Sep; 40(3):273-285. PubMed ID: 31065042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Science organisations and Coca-Cola's 'war' with the public health community: insights from an internal industry document.
    Barlow P; Serôdio P; Ruskin G; McKee M; Stuckler D
    J Epidemiol Community Health; 2018 Sep; 72(9):761-763. PubMed ID: 29540465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coca-Cola - a model of transparency in research partnerships? A network analysis of Coca-Cola's research funding (2008-2016).
    Serôdio PM; McKee M; Stuckler D
    Public Health Nutr; 2018 Jun; 21(9):1594-1607. PubMed ID: 29560842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research partnerships between Coca-Cola and health organizations in Spain.
    Rey-López JP; Gonzalez CA
    Eur J Public Health; 2019 Oct; 29(5):810-815. PubMed ID: 30169613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coca-Cola's political and policy influence in Mexico: understanding the role of institutions, interests and divided society.
    Gómez EJ
    Health Policy Plan; 2019 Sep; 34(7):520-528. PubMed ID: 31381805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Coca-Cola Shaped the International Congress on Physical Activity and Public Health: An Analysis of Email Exchanges between 2012 and 2014.
    Wood B; Ruskin G; Sacks G
    Int J Environ Res Public Health; 2020 Dec; 17(23):. PubMed ID: 33287097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies used by the soft drink industry to grow and sustain sales: a case-study of The Coca-Cola Company in East Asia.
    Huse O; Reeve E; Bell C; Sacks G; Baker P; Wood B; Backholer K
    BMJ Glob Health; 2022 Dec; 7(12):. PubMed ID: 36593644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soda industry influence on obesity science and policy in China.
    Greenhalgh S
    J Public Health Policy; 2019 Mar; 40(1):5-16. PubMed ID: 30626895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating industry attempts to influence public health: Applying an ethical framework in understanding commercial determinants of health.
    Ndebele P; Krisko P; Bari I; Paichadze N; Hyder AA
    Front Public Health; 2022; 10():976898. PubMed ID: 36203686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The corporate influence on food charity and aid: The "Hunger Industrial Complex" and the death of welfare.
    Caraher M; Furey S
    Front Public Health; 2022; 10():950955. PubMed ID: 36062087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are industry-funded charities promoting "advocacy-led studies" or "evidence-based science"?: a case study of the International Life Sciences Institute.
    Steele S; Ruskin G; Sarcevic L; McKee M; Stuckler D
    Global Health; 2019 Jun; 15(1):36. PubMed ID: 31155001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobbying against sugar taxation in the European Union: Analysing the lobbying arguments and tactics of stakeholders in the food and drink industries.
    Tselengidis A; Östergren PO
    Scand J Public Health; 2019 Jul; 47(5):565-575. PubMed ID: 29974816
    [No Abstract]   [Full Text] [Related]  

  • 16. Complexity and conflicts of interest statements: a case-study of emails exchanged between Coca-Cola and the principal investigators of the International Study of Childhood Obesity, Lifestyle and the Environment (ISCOLE).
    Stuckler D; Ruskin G; McKee M
    J Public Health Policy; 2018 Feb; 39(1):49-56. PubMed ID: 29180754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How are frames generated? Insights from the industry lobby against the sugar tax in Ireland.
    Campbell N; Mialon M; Reilly K; Browne S; Finucane FM
    Soc Sci Med; 2020 Nov; 264():113215. PubMed ID: 32889504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pushing partnerships: corporate influence on research and policy via the International Life Sciences Institute.
    Steele S; Ruskin G; Stuckler D
    Public Health Nutr; 2020 Aug; 23(11):2032-2040. PubMed ID: 32416734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sponsorship of National Health Organizations by Two Major Soda Companies.
    Aaron DG; Siegel MB
    Am J Prev Med; 2017 Jan; 52(1):20-30. PubMed ID: 27745783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vested interests in addiction research and policy. The challenge corporate lobbying poses to reducing society's alcohol problems: insights from UK evidence on minimum unit pricing.
    McCambridge J; Hawkins B; Holden C
    Addiction; 2014 Feb; 109(2):199-205. PubMed ID: 24261642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.